Cargando…

Secukinumab-Induced Lymphocytic Colitis

Secukinumab an interleukin-17 (IL-17) monoclonal antibody inhibitor is currently approved for the treatment of rheumatological conditions, such as psoriasis and ankylosing spondylitis. Lymphocytic colitis, a phenotype of microscopic colitis, is a long-term inflammatory condition, is characterized by...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gandu, Siva Santosh Kumar, Khan, Mohammad Hassaan, Vasikaran, Anush, Pandit, Sudha
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2022
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9272475/ https://www.ncbi.nlm.nih.gov/pubmed/35801542 http://dx.doi.org/10.1177/23247096221110399

Ejemplares similares

A Rare Case of New-Onset Ulcerative Colitis following Initiation of Secukinumab
por: Achufusi, Ted George, et al.
Publicado: (2019)

A223 UNMASKED OR INDUCED COLITIS: COULD IT BE SECUKINUMAB?
por: Nassiri, S, et al.
Publicado: (2023)

A Challenging Case of Severe Ulcerative Colitis following the Initiation of Secukinumab for Ankylosing Spondylitis
por: Ehrlich, Dean, et al.
Publicado: (2018)

Secukinumab-induced chronic discoid lupus erythematosus
por: Chatzimichail, Giannis, et al.
Publicado: (2020)

Secukinumab-induced Raynaud’s phenomenon: first report in the literature
por: Kobak, Senol
Publicado: (2020)

Granuloma Annulare in the Setting of Secukinumab
por: Clark, Matthew L., et al.
Publicado: (2018)

Paradoxical Arthralgia Secondary to Anti-Tumor-Necrosis-Factor Alpha Therapy in Crohn’s Disease
por: Thurlapati, Aswani, et al.
Publicado: (2021)

Secukinumab induced Behçet’s syndrome: a report of two cases
por: Dincses, Elif, et al.
Publicado: (2019)

Herpetiform aphthous ulcerations induced by secukinumab: Report of 2 cases
por: Benzaquen, Michael, et al.
Publicado: (2020)

Successful use of secukinumab in pustular psoriasis
por: Yeung, Jensen, et al.
Publicado: (2016)

Secukinumab and hidradenitis suppurativa: Friends or foes?
por: Marasca, Claudio, et al.
Publicado: (2019)

Successful use of secukinumab in Netherton syndrome
por: Blanchard, Sarah K., et al.
Publicado: (2020)

Secukinumab treatment of Parry-Romberg syndrome
por: Sideris, Emily, et al.
Publicado: (2020)

Possible autoimmune hemolytic anemia induced by secukinumab: a case report
por: Rahman, Perdana Aditya, et al.
Publicado: (2022)

Severe, ulcerative, lichenoid mucositis associated with secukinumab
por: Thompson, Jordan M., et al.
Publicado: (2016)

Role of secukinumab in ankylosing spondylitis with tubercular uveitis
por: Mahendradas, Padmamalini, et al.
Publicado: (2020)

Secukinumab Therapy in Refractory Juvenile Idiopathic Arthritis
por: Nelson, Meghan Corrigan, et al.
Publicado: (2023)

Pyoderma gangrenosum induced by secukinumab in a patient with psoriasis successfully treated with ustekinumab
por: Petty, Amy J., et al.
Publicado: (2020)

Active pulmonary tuberculosis in a patient with secukinumab treatment
por: Ngoc, Cao Thanh, et al.
Publicado: (2022)

A Case of Granuloma Annulare Associated with Secukinumab Use
por: Bonomo, Lauren, et al.
Publicado: (2017)

Efficacy of Secukinumab for Plaque Psoriasis in a Patient on Hemodialysis
por: Ikuma, Daiuske, et al.
Publicado: (2019)

Sarcoidosis manifesting during treatment with secukinumab for psoriatic arthritis
por: Kirby, Colm, et al.
Publicado: (2021)

Novel Presentation of Terminal Ileitis Associated with Secukinumab Therapy
por: Ahmed Shaheen, Aciel, et al.
Publicado: (2021)

Secukinumab-Induced Alopecia Areata Successfully Treated with Tofacitinib in a Patient with Palmoplantar Pustulosis
por: Zhang, Chen, et al.
Publicado: (2023)

Lymphocytic Colitis Diagnosis 40 Years after Onset of Ulcerative Colitis
por: Stavrakis, Dimitris, et al.
Publicado: (2018)

Successful treatment of type II pityriasis rubra pilaris with secukinumab
por: Gauci, Marie-Léa, et al.
Publicado: (2016)

A Case of Moderate Hidradenitis Suppurativa and Psoriasis Treated with Secukinumab
por: Giuseppe, Pistone, et al.
Publicado: (2018)

Acrodermatitis of Hallopeau and erosive oral mucositis successfully treated with secukinumab
por: Baron, Jennifer A.
Publicado: (2017)

Progression of Pre-Existing Vitiligo during Secukinumab Treatment for Psoriasis
por: Kim, Jin Cheol, et al.
Publicado: (2023)

Treatment of Erythrodermic Psoriasis in Children with Secukinumab: A Case Report
por: Lu, Xujun, et al.
Publicado: (2023)

New-Onset Collagenous Colitis in a Patient With Psoriatic Arthritis: Can It Be Secukinumab?
por: Obeidat, Adham E, et al.
Publicado: (2021)

Immune Checkpoint Inhibitor-Induced Colitis Presenting As Lymphocytic Colitis
por: Khan, Jaffar, et al.
Publicado: (2021)

Pyoderma gangrenosum treated with secukinumab: A case report
por: McPhie, Meghan L, et al.
Publicado: (2020)

Rapid Onset of Inflammatory Bowel Disease after Receiving Secukinumab Infusion
por: Wang, Jingzhou, et al.
Publicado: (2018)

Resolution of post-adalimumab vitiligo with secukinumab in a patient with psoriasis vulgaris
por: Palazzo, Giovanni
Publicado: (2020)

Corrigendum to “A Rare Case of New-Onset Ulcerative Colitis following Initiation of Secukinumab”
por: Achufusi, Ted George, et al.
Publicado: (2019)

SARS-CoV-2-triggered lymphocytic colitis
por: Nassar, Islam Osama, et al.
Publicado: (2021)

mRNA-1273: Lymphocytic colitis: case report
Publicado: (2021)

Medically Refractory Lymphocytic Colitis Successfully Treated With Upadacitinib
por: Miyatani, Yusuke, et al.
Publicado: (2023)

Transition from secukinumab to adalimumab in COVID‐19‐induced psoriasis flare‐up treatment: A case report
por: Chen, Yuting, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_gvvrlq4rjf725acolefu3hg603